Last reviewed · How we verify
Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
To determine the safety and tolerability of repeated dosing with Apomorphine Nasal Powder in subjects with Parkinson's Disease.
Details
| Lead sponsor | Britannia Pharmaceuticals Ltd. |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | COMPLETED |
| Enrolment | 36 |
| Start date | 2006-07 |
| Completion | 2007-08 |
Conditions
- Parkinson's Disease
Interventions
- Apomorphine Nasal Powder